To establish the pathological relevance of the anti-correlation between MYC overexpression and ESR1/GATA3 downregulation, we assessed the expression level of these ML-specific TFs in large cohorts of breast cancer samples. This evidence concerns the gene ESR1 and breast carcinoma.